sellModerate
Versant Venture Capital VI, L.P. sold $4.1M of LVTX
owner at LAVA Therapeutics NV. 2,903,403 shares at an average of $1.40, traded Sep 19, 2025, filed Sep 23, 2025.
Warning score
57Value
$4.1M
2,903,403 shares
Holdings after
0
-122% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +12Role10% owner
- +25Trade size$4.1M at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001193125-25-213445, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 19, 2025 | SOpen-market sale Common Stock | -2,370,533 | $1.40 | $3.3M | 0 | Sep 23, 2025 |
| Sep 19, 2025 | SOpen-market sale Common Stockindirect: See Footnote | -532,870 | $1.40 | $747k | 0 | Sep 23, 2025 |
Related signals
Other insiders at LAVA Therapeutics NV and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 57Moderate | LVTXsell LAVA Therapeutics NV | Gilde Healthcare U.A. Cooperatieve IV owner | $4.2M 2,871,370 shares | -97% | |
| 33Weak | LVTXsell LAVA Therapeutics NV | Gilde Healthcare U.A. Cooperatieve IV owner | $719k 475,027 shares | -9% | |
| 24Weak | LVTXsell LAVA Therapeutics NV | Gilde Healthcare U.A. Cooperatieve IV owner | $198k 126,992 shares | -2% | |
| 47Moderate | LVTXsell LAVA Therapeutics NV | Versant Venture Capital VI, L.P. owner | $2.5M 1,684,434 shares | -49% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.